No Detail Found!

CDX2 Expression: development of lower esophageal adenocarcinoma

Author(s)
Humera Jabeen Peshawar Medical College, Peshawar Pakistan
Lubna Avesi Dow International Medical College, Dow University of Health Sciences, Karachi Pakistan
Saba Hassan Shamim Dow International Medical College, Dow University of Health Sciences, Karachi Pakistan
Farheen Danish Dow International Medical College, Dow University of Health Sciences, Karachi Pakistan
Nazia Qamar Fazaia Ruth Pfau Medical College, Karachi Pakistan
Maryam Moula Bakhsh Dow Institute of Technology, Dow University of Health Sciences, Pakistann
Abstract
Objectives: To look into the expression of CDX2 in normal and various abnormal esophageal epithelial conditions in human subjects. Material and Methods: This study was conducted at Department of Pathology, Dow University of Health Sciences and Al-Tibri Medical College, Karachi. After ERC (ethical review committee) approval 88 human subjects were selected through non-probability sampling using inclusion and exclusion criteria 22 subjects as control (group-I) and 22 individuals with Barrett esophagus (Group-II), 22 patients with dysplasia (Group-III) and 22 known patients of esophageal adenocarcinoma (Group-IV). Demographic data were collected on proforma while histopathological changes and biomarkers were evaluated by the department of pathology, Chi-square was the statistical techniques used. Results: There were 70 (79.55%) males and 18 (21.45%) females. The mean age was 43.09±6.52 years in group-I while 56.63±2.64 years in group-II and 61.68±4.23 years in group-III whereas it was 63.90±3.80 years in group IV. CDX-2 was found expressed in 36(40.91%) patients where as it was negative in 52 (59.09%) patients. Conclusion: There is significant association in CDX2 expression in various epithelial abnormalities of the esophagus from Barrett esophagus to esophageal adenocarcinoma.
Publication Details
Page(s) 111-113
DOI DOI not available
Published Journal: Pakistan Journal of Pathology, Volume: 31, Issue: 4, Year: 2020

Request the full text from PASTIC

Keywords
CDX2, Adenocarcinoma., Dysplasia
0

Citations

0

Downloads

52

Views